ATPW
ABBV icon

Ashton Thomas Private Wealth’s AbbVie ABBV Stock Holding History

Ashton Thomas Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Buy
68,818
+26,473
+63% +$5.87M 0.35% 65
2025
Q4 		$9.68M Sell
42,345
-2,232
-5% -$508K 0.24% 91
2025
Q3 		$10.3M Buy
44,577
+3,633
+9% +$740K 0.27% 85
2025
Q2 		$7.6M Buy
40,944
+1,543
+4% +$287K 0.27% 91
2025
Q1 		$8.26M Buy
39,401
+1,479
+4% +$288K 0.32% 75
2024
Q4 		$6.74M Buy
37,922
+8,091
+27% +$1.49M 0.26% 91
2024
Q3 		$5.89M Buy
29,831
+692
+2% +$129K 0.31% 80
2024
Q2 		$5M Buy
29,139
+1,628
+6% +$270K 0.27% 91
2024
Q1 		$5.01M Buy
27,511
+3,265
+13% +$563K 0.29% 94
2023
Q4 		$3.76M Sell
24,246
-174
-0.7% -$25.4K 0.24% 119
2023
Q3 		$3.64M Buy
24,420
+312
+1% +$45.8K 0.27% 104
2023
Q2 		$3.25M Buy
24,108
+7,516
+45% +$1.1M 0.25% 113
2023
Q1 		$2.64M Buy
16,592
+467
+3% +$71.4K 0.23% 118
2022
Q4 		$2.61M Sell
16,125
-9,497
-37% -$1.46M 0.26% 109
2022
Q3 		$3.44M Buy
25,622
+7,165
+39% +$1.03M 0.39% 70
2022
Q2 		$2.83M Buy
18,457
+4,681
+34% +$715K 0.31% 93
2022
Q1 		$2.23M Buy
13,776
+3,122
+29% +$454K 0.2% 140
2021
Q4 		$1.44M Buy
10,654
+2,230
+26% +$263K 0.14% 180
2021
Q3 		$909K Sell
8,424
-1,350
-14% -$154K 0.13% 170
2021
Q2 		$1.1M Buy
9,774
+309
+3% +$34.8K 0.17% 150
2021
Q1 		$1.02M Sell
9,465
-3,663
-28% -$392K 0.17% 141
2020
Q4 		$1.41M Sell
13,128
-4,544
-26% -$437K 0.27% 103
2020
Q3 		$1.55M Sell
17,672
-4,857
-22% -$457K 0.39% 70
2020
Q2 		$2.21M Buy
22,529
+5,310
+31% +$468K 0.66% 41
2020
Q1 		$1.31M Buy
+17,219
New +$1.47M 0.54% 54
2019
Q2 		– Sell
-2,517
Closed -$203K – 183
2019
Q1 		$203K Buy
+2,517
New +$206K 0.08% 191

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ashton Thomas Private Wealth's ABBV Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its AbbVie (ABBV) stake by 63% in Q1 2026, buying an estimated $5.87M and bringing the position to 68,818 shares worth $15M. The position accounts for 0.35% of the portfolio, ranked #65.

Ashton Thomas Private Wealth first reported a position in ABBV in Q1 2019 and has held it in 26 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Ashton Thomas Private Wealth held 68,818 shares of AbbVie worth $15M as of Q1 2026.
  • Ashton Thomas Private Wealth bought 26,473 AbbVie shares in Q1 2026, an estimated $5.87M.
  • AbbVie made up 0.35% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #65 holding.
  • Ashton Thomas Private Wealth first reported a position in AbbVie in Q1 2019 and has held it in 26 quarters since.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.